Variation in the Human Genome and the Inherited Basis of Common Disease

https://doi.org/10.1053/j.seminoncol.2006.11.001Get rights and content

The availability of a reference human genome sequence–an increasingly dense catalog–knowledge of common genetic variation, and new developments in technology present an unprecedented opportunity to systematically explore the genetic basis of complex human diseases such as cancer. An understanding of the common mutations that can cause distinct human cancers will be critical for identifying new targets for drug discovery, patient stratification for clinical trials, and analysis of drug response data to delineate classes of patients that respond to therapy. The genome structure of cancer can be investigated in several ways. Germline mutations can be investigated in large-scale, case-control, or family studies. Somatic alternations can be identified using state-of-the-art genomic technologies such as high-density oligonucleotide arrays and targeted resequencing. Combined, these approaches will lead to a better understanding of the cancer genome.

Section snippets

Examples of the Utility of Haplotype-Based Studies

Two recent examples of haplotype-based studies illustrate the power of the approach and the dramatic effect the identification of risk alleles for common disease could have on human heath. The first is the discovery of a common allele which explains a substantial portion of risk for the debilitating blindness disease, AMD. Only a subset of published linkage studies of AMD displayed modest positive LOD scores across a region of chromosome 1.25 However, whole-genome association analysis16 and

Considerations for Cancer

The use of genetics and genomics technologies offers great promise for cancer research. Cancer presents a particular challenge, compared with the genetic studies discussed earlier, because each human cancer is composed of two genomes: the germline and the somatic genome. Tools to discover heritable germline variants for cancer risk are the same as discussed above for other common, complex diseases, and should be greatly enabled in the coming year through use of HapMap and the application of

Conclusion

In summary, the fruits of the complete human genome sequence and the HapMap project coupled with technologic advances offer unprecedented opportunities to completely characterize the somatic cancer genome and the risk contributed by common variations in the germline to cancer risk.

References (31)

  • D.E. Reich et al.

    Quality and completeness of SNP databases

    Nat Genet

    (2003)
  • W.J. Strittmatter et al.

    Apolipoprotein E and Alzheimer disease

    Proc Natl Acad Sci U S A

    (1995)
  • B. Dahlback

    Resistance to activated protein C caused by the factor VR506Q mutation is a common risk factor for venous thrombosis

    Thromb Haemost

    (1997)
  • D. Altshuler et al.

    The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes

    Nat Genet

    (2000)
  • L. Nistico et al.

    The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetesBelgian Diabetes Registry

    Hum Mol Genet

    (1996)
  • Cited by (7)

    • Genetic factors and molecular mechanisms in dry eye disease

      2018, Ocular Surface
      Citation Excerpt :

      Genetic variations can occur as DNA sequence repeats, insertions or deletions [88]. The most commonly occurring gene variants are single nucleotide polymorphisms (SNPs) and these have developed within humans over time passing down through generations [88,89]. SNPs are considered relevant when detected in greater than 1% of the population [88,90].

    • Sasang constitution affects the prevalence of functional dyspepsia

      2015, BMC Complementary and Alternative Medicine
    View all citing articles on Scopus
    View full text